Vanguard Group Inc. Grows Holdings in Astera Labs, Inc. $ALAB

Vanguard Group Inc. boosted its position in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) by 14.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,743,141 shares of the company’s stock after acquiring an additional 1,693,918 shares during the period. Vanguard Group Inc. owned 8.27% of Astera Labs worth $2,690,907,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the company. Assetmark Inc. increased its stake in shares of Astera Labs by 374.1% in the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares in the last quarter. Whittier Trust Co. bought a new position in Astera Labs in the 3rd quarter worth $55,000. Atlantic Union Bankshares Corp increased its stake in Astera Labs by 1,338.1% in the 3rd quarter. Atlantic Union Bankshares Corp now owns 302 shares of the company’s stock worth $59,000 after buying an additional 281 shares in the last quarter. Grove Bank & Trust purchased a new stake in Astera Labs in the 3rd quarter worth $68,000. Finally, Cullen Frost Bankers Inc. raised its holdings in Astera Labs by 1,560.0% during the third quarter. Cullen Frost Bankers Inc. now owns 415 shares of the company’s stock valued at $81,000 after acquiring an additional 390 shares during the period. 60.47% of the stock is currently owned by institutional investors.

Insider Activity

In related news, Director Manuel Alba sold 150,000 shares of the company’s stock in a transaction dated Monday, December 1st. The shares were sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director directly owned 1,574,498 shares in the company, valued at approximately $261,650,077.64. This represents a 8.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 12.50% of the company’s stock.

Astera Labs Price Performance

NASDAQ:ALAB opened at $129.58 on Thursday. The firm has a market capitalization of $21.89 billion, a price-to-earnings ratio of 106.21, a PEG ratio of 2.43 and a beta of 1.50. The business has a 50 day simple moving average of $161.60 and a 200-day simple moving average of $174.41. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90.

Astera Labs (NASDAQ:ALABGet Free Report) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The firm had revenue of $270.58 million for the quarter, compared to the consensus estimate of $249.46 million. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.The company’s revenue for the quarter was up 91.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. As a group, analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Northland Securities increased their target price on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. BNP Paribas Exane initiated coverage on shares of Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating on the stock. Wall Street Zen downgraded shares of Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Morgan Stanley restated an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Royal Bank Of Canada started coverage on shares of Astera Labs in a report on Wednesday, January 14th. They issued an “outperform” rating and a $225.00 price target on the stock. Fourteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $192.89.

View Our Latest Stock Report on ALAB

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Read More

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.